01.11.24 -- Clinical Trial Supply Market Outlook, Developments, And Technology Trends

Explore the challenges of defining and measuring “quality” IRB review and certain key efforts by research community stakeholders to overcome such obstacles.

See how transformative technologies such as AI and ML augment the regulatory professional workload to ensure compliance, patient accessibility, and rapid timelines for approval for global drug campaigns.

Since 1939, see how Pink Sheet has helped sponsors stay on top of critical developments in today’s complex pharma regulatory environment.

Learn the reasons why depth of management typically is less about ensuring your trial progresses smoothly and more about hiding the CRO’s deficiencies or appeasing its own stakeholders.

The biopharmaceutical sector is currently undergoing significant transformations. Uncover three critical elements for implementing new functional service provider partnerships for streamlining developments.

Consider locations in the Asia-Pacific region, such as South Korea and China, to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs.